MalarkeyM. Notice of initiation of disqualification proceeding and opportunity to explain (letter to Charles E Runels Jr, 27 August 2008). Food and Drug Administration, Center for Biologics Evaluation and Research, http://www.circare.org/fdawls3/runels_20080827.pdf (2008, accessed 25 May 2017).
2.
MalarkeyMRobertsJV. Chair Patient Advocacy Council (1 February 2007). Food and Drug Administration, Center for Biologics Evaluation and Research, http://www.circare.org/fdawls/pacirb_20070201.pdf (2007, accessed 25 May 2017).
Department of Health Education and Welfare. The national commission for the protection of human subjects of biomedical and behavioral research. The Belmont Report, 18April, https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/ (1979, accessed 25 May 2017).
12.
PikeER. Recovering from research: a no-fault proposal to compensate injured research participants. Am J Law Med2012; 38: 7–62.
13.
MitfordJ. Experiments behind bars: doctors, drug companies and prisoners. Atl Mon1973; 76: 64–73.
MonahanTFisherJA. “I’m still a hustler”: entrepreneurial responses to precarity by participants in phase I clinical trials. Econ Soc2015; 44: 545–566.
18.
CottinghamMDFisherJA. Risk and emotion among healthy volunteers in clinical trials. Soc Psychol Q2016; 79: 222–242.
19.
FisherJA. Feeding and bleeding: the institutional banalization of risk to healthy volunteers in phase I pharmaceutical clinical trials. Sci Technol Human Values2015; 40: 199–226.